Short Interest in BioCorRx Inc. (OTCMKTS:BICX) Expands By 100.0%

BioCorRx Inc. (OTCMKTS:BICX) was the target of a significant increase in short interest in April. As of April 15th, there was short interest totalling 800 shares, an increase of 100.0% from the March 31st total of 400 shares. Based on an average daily volume of 2,800 shares, the days-to-cover ratio is presently 0.3 days.

BioCorRx Price Performance

BICX remained flat at $0.82 during trading on Friday. The company’s stock had a trading volume of 7,500 shares, compared to its average volume of 1,740. The firm’s 50 day simple moving average is $1.02 and its 200 day simple moving average is $1.07. The company has a market capitalization of $7.30 million, a P/E ratio of -1.82 and a beta of 0.59. BioCorRx has a twelve month low of $0.67 and a twelve month high of $2.22.

BioCorRx (OTCMKTS:BICX) last issued its quarterly earnings results on Monday, April 1st. The company reported ($0.11) earnings per share for the quarter. The firm had revenue of $0.02 million during the quarter.

BioCorRx Company Profile

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.